Navigation Links
Risk of heart disease prediction needs updating

According to researchers at the Mayo Clinic, the present risk of prognosis methods in heart disease need to take account of more factors if they are to be useful in assessing a patient's future health.// When someone has a heart attack or is at risk of having one what they want to know most of all is what the future might hold. Doctors can use the prediction tools and use to counsel them.

The team compared two commonly used heart disease prediction models - one is called TIMI, and it's based upon clinical trial data. The other, known as PREDICT, comes from whole population data. The researchers compared these in a group of people from Olmsted County, recording 1134 heart attacks over a 12 year period.

Put simply, PREDICT was more accurate in predicting future survival for those who'd had a heart attack. The researchers believe this is because it is based upon data from the general population and includes co-existing problems like hypertension and diabetes. They also find that adding information on the patient's ejection fraction - a measure of heart muscle strength - made the models even more accurate. The study should help doctors give heart patients better information about their future health, which will guide treatment and lifestyle decisions.


'"/>




Page: 1

Related medicine news :

1. Starvation in pregnant women can cause heart disease to their children
2. Individuals with sleep related breathing disorders more prone to heart disease
3. And now they say infections can cause heart disease!!!!
4. And now they say infections can cause heart disease!!!!
5. Award for TTK Chitra heart valve prosthesis
6. Eat greens to have a ever green heart
7. Asthma! A new warning for heart disease
8. Protein in urine foresees heart disease
9. One...just one cigarette can spoil the heart function.
10. Risk of heart disease begins in teens
11. Beer vitamin protects heart
Post Your Comments:
(Date:7/18/2008)...wswire/ -- In the last ten years over 360,children... average of 36,per year, according to a study by M...ces., (See video from General Motors (NYSE: GM...y=35362 ) Hyperthermia is the overheating of the ...s a car can become for a small child in just a few...
(Date:7/18/2008)...uly 18 /PRNewswire-USNewswire/ -- Two consumer,gro...controversial patent,on human embryonic stem cells...(WARF)., Consumer Watchdog, formerly The Foundati...c Patent Foundation appealed to the U.S. Patent,Of... examiner narrowed,WARF,s patent after the two gro...
(Date:7/18/2008)... New research led by a Michigan State University ...rweight workers are lazier, more emotionally unsta...l weight" colleagues. , With the findings, emplo...based stereotypes when it comes to hiring, promoti...or of human resource management, and two colleague...
(Date:7/18/2008)...Newswire/ -- Highmark Blue Cross Blue Shield,Unit...s will join forces to,promote healthy smiles and l...and continuing until 3 p.m., tomorrow, July 19, a ...al screenings, restorations and sealants,for those...ived much less attention in,American culture than ...
Breaking Medicine News(10 mins):Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:Studies refute common stereotypes about obese workers 2Health News:Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday 2
...als have confirmed that the culling operations in ...orted will end on Monday.// Dr B K Wankhade, Regio...hat the operations had begun on March 29 after the...h workers in 82 teams were involved in the operati...
... have confirmed that there has been an outbreak of...er in about 29// villages of Nasik district. Aroun...e have been hospitalized. Malegon was the worst a...18 that were sent to the National Institute of Vir...
...h a new technique for treating the children who su...ease the pain and also prevents deformity. // Int... Hospital outlined his technique for injecting ste... arthritis patients at the Society of Intervention...
...pulation carries the deadly hepatitis virus, a gro...titis B and C is a time bomb waiting to explode un...rol it," said the president of the Pakistan Medica...b, quoting the organisation's annual 2006 report. ...
Other Medicine News:
(Date:7/16/2008)... of men rank discomfort as #1 reason to avoid disc...to heart disease, INDIANAPOLIS, July 16 /PRNewswi...2 percent of men with erectile dysfunction (ED) su...h conditions, such as heart,disease and diabetes, ...on,with their doctors. The survey, conducted by Ip...
(Date:7/16/2008)... Raptor to Support Phase 2a Clinical Trial at UCS... -- Raptor,Pharmaceuticals Corp. ("Raptor" or the ...nced the execution of a collaboration agreement (t... San Diego ("UCSD") to,include a Phase 2a clinical...f cysteamine bitartrate ("Cysteamine") in adolesce...
(Date:7/15/2008)... July 15 /PRNewswire-USNewswire/ -- A man sufferin...ian Hospital of Dallas ER and was,eventually treat... cardiac,catheterization lab in 28 minutes. The pr...ventional cardiologist at Presbyterian, involved u...ery and illustrates the,importance of providing tr...
(Date:7/15/2008)...- Company Reports Favorable Phase 1 RX-3341 Result...b-X Pharmaceuticals, Inc.,("Rib-X" or the "Company...covery and development of novel antibiotics for th...day announced the initiation of a Phase,2 clinical...und RX-3341 in,the treatment of complicated skin a...
Breaking Medicine Technology:The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Record 'Door-to-Balloon' Time at Presbyterian Hospital of Dallas 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3USP announces 2008 summer internship program participants 17031 1USP announces 2008 summer internship program participants 17031 2More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 1More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 2Aflac Incorporated To Release First Quarter Results on April 23 2008 17028 1Aflac Incorporated To Release First Quarter Results on April 23 2008 17028 2Torchmark Corporation Reports First Quarter 2008 Results 17026 1Torchmark Corporation Reports First Quarter 2008 Results 17026 2Torchmark Corporation Reports First Quarter 2008 Results 17026 3Torchmark Corporation Reports First Quarter 2008 Results 17026 4Torchmark Corporation Reports First Quarter 2008 Results 17026 5Torchmark Corporation Reports First Quarter 2008 Results 17026 6Torchmark Corporation Reports First Quarter 2008 Results 17026 7Torchmark Corporation Reports First Quarter 2008 Results 17026 8Torchmark Corporation Reports First Quarter 2008 Results 17026 9
... /PRNewswire-FirstCall/ -,MIGENIX Inc. , a clinica... will make a presentation of results from a recent...ee April 11, 2007,press release) in a non-responde...W) 2007 being held in Washington, DC May 19-24,20...atitis,Investigative Unit (VHIU) at the Health Sci...
...swire-FirstCall/ -- A total,of 20 oral and poster ...ough,s hepatitis products, including PEGINTRON(TM)..., USP) combination,therapy for chronic hepatitis C... 503034), the company,s investigational oral HCV,p...evelopment, will,be presented by leading researche...
Other Medicine Technology:Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 2Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
...cal Table is built to the same rigorous engineerin...al purpose surgical tables, and includes many of t...for enhanced full body imaging. Standard, extremel...ty of accessories. The 1700 Series Table features ...
The schaereraxis 200/300 product range includes 10 different models which have been designed for the varied requirements of different disciplines, whether in the surgical practice, in outpatient surg
... Cmax operating table that combines all the positi...h the radiolucence and precise mobility of an imag...surgical table on the market. The Cmax table is de...res and imaging techniques and has six patented in...
...ability, access, and precise, quiet, vibration-fre...tenuation carbon fiber tabletop accommodates porta...rea is free of cross members, allowing full fluoro...oning. Functional design provides complete access ...
Medicine Products: